CHCT
Community Healthcare Trust Incorporated [CHCT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CHCT Stock Summary
Top 10 Correlated ETFs
CHCT
Top 10 Correlated Stocks
CHCT
In the News
CHCT Financial details
Company Rating
Buy
Market Cap
696.18M
Income
7.71M
Revenue
112.85M
Book val./share
19.76
Cash/share
0.13
Dividend
1.81
Dividend %
7.05%
Employees
37
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
77.87
Forward P/E
-
PEG
-10.51
P/S
6.4
P/B
1.25
P/C
194.15
P/FCF
14.73
Quick Ratio
0.89
Current Ratio
0.95
Debt / Equity
0.79
LT Debt / Equity
0.7
-
-
EPS (TTM)
0.21
EPS next Y
-
EPS next Q
-
EPS this Y
-75.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-11.58%
Revenue last 5Y
13.15%
Revenue Q/Q
1.35%
EPS Q/Q
36.36%
-
-
-
-
SMA20
-7.41%
SMA50
-
SMA100
-7.41%
Inst Own
71.02%
Inst Trans
0.72%
ROA
1%
ROE
2%
ROC
0.05%
Gross Margin
82%
Oper. Margin
41%
Profit Margin
8%
Payout
560%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
24.5-37.15
52W High
-31.78%
52W Low
+5.17%
RSI
42
Rel Volume
0.41
Avg Volume
195.11K
Volume
79.6K
Perf Week
-0.28%
Perf Month
-6.14%
Perf Quarter
-8.85%
Perf Half Y
-12.33%
-
-
-
-
Beta
0.649
-
-
Volatility
0.17%, 0.71%
Prev Close
1.12%
Price
25.24
Change
2.02%
CHCT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.26 | 3.51 | 3.89 | 4.13 | 4.48 | |
| Net income per share | 0.45 | 0.88 | 0.97 | 0.93 | 0.31 | |
| Operating cash flow per share | 1.73 | 2.24 | 2.42 | 2.55 | 2.44 | |
| Free cash flow per share | 1.5 | 1.92 | 2.11 | 2.11 | 1.68 | |
| Cash per share | 0.09 | 0.12 | 0.12 | 1.43 | 0.14 | |
| Book value per share | 18.91 | 19.93 | 19.86 | 21.02 | 20.37 | |
| Tangible book value per share | 18.91 | 19.9 | 19.84 | 20.92 | 20.26 | |
| Share holders equity per share | 18.91 | 19.93 | 19.86 | 21.02 | 20.37 | |
| Interest debt per share | 11.7 | 10.28 | 12.39 | 15.45 | 16.87 | |
| Market cap | 800.83M | 1.02B | 1.1B | 845.99M | 671.38M | |
| Enterprise value | 993.35M | 1.23B | 1.36B | 1.19B | 1.08B | |
| P/E ratio | 95.61 | 53.28 | 48.89 | 38.42 | 87.03 | |
| Price to sales ratio | 13.16 | 13.43 | 12.14 | 8.66 | 5.95 | |
| POCF ratio | 24.75 | 21.01 | 19.52 | 14.03 | 10.94 | |
| PFCF ratio | 28.61 | 24.57 | 22.38 | 16.95 | 15.83 | |
| P/B Ratio | 2.27 | 2.36 | 2.38 | 1.7 | 1.31 | |
| PTB ratio | 2.27 | 2.36 | 2.38 | 1.7 | 1.31 | |
| EV to sales | 16.32 | 16.21 | 15.05 | 12.16 | 9.53 | |
| Enterprise value over EBITDA | 24.03 | 22.89 | 21.51 | 17.92 | 16.2 | |
| EV to operating cash flow | 30.69 | 25.37 | 24.19 | 19.7 | 17.52 | |
| EV to free cash flow | 35.49 | 29.66 | 27.74 | 23.8 | 25.36 | |
| Earnings yield | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | |
| Free cash flow yield | 0.03 | 0.04 | 0.04 | 0.06 | 0.06 | |
| Debt to equity | 0.59 | 0.5 | 0.6 | 0.71 | 0.79 | |
| Debt to assets | 0.37 | 0.32 | 0.37 | 0.4 | 0.43 | |
| Net debt to EBITDA | 4.66 | 3.93 | 4.15 | 5.16 | 6.09 | |
| Current ratio | 0.56 | 0.77 | 0.37 | 1.06 | 1.04 | |
| Interest coverage | 2.05 | 3.26 | 3.13 | 2.86 | 3.65 | |
| Income quality | 3.86 | 2.54 | 2.51 | 2.74 | 7.96 | |
| Dividend Yield | 0.04 | 0.04 | 0.04 | 0.05 | 0.07 | |
| Payout ratio | 3.81 | 1.99 | 1.89 | 2.02 | 6.23 | |
| Sales general and administrative to revenue | 0.13 | 0.12 | 0.13 | 0.15 | 0.24 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.14 | -0.14 | -0.13 | -0.17 | -0.31 | |
| Capex to revenue | -0.07 | -0.09 | -0.08 | -0.11 | -0.17 | |
| Capex to depreciation | -0.19 | -0.27 | -0.23 | -0.31 | -0.47 | |
| Stock based compensation to revenue | 0.06 | 0.06 | 0.08 | 0.1 | 0.18 | |
| Graham number | 13.81 | 19.91 | 20.79 | 20.99 | 11.84 | |
| ROIC | 0.03 | 0.04 | 0.04 | 0.04 | 0.07 | |
| Return on tangible assets | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 | |
| Graham Net | -9.76 | -9.2 | -11.06 | -13.4 | -13.9 | |
| Working capital | -1.58M | -9.46M | -4.98M | 691K | 2.82M | |
| Tangible asset value | 353.27M | 429.3M | 461.5M | 494.42M | 510.61M | |
| Net current asset value | -207.1M | -206.61M | -289.25M | -367.54M | -361.93M | |
| Invested capital | 0.59 | 0.5 | 0.6 | 0.71 | 0.79 | |
| Average receivables | 30.66M | 30.09M | 35.75M | 48.48M | 55.39M | |
| Average payables | 1.8M | 4.67M | 6.79M | 9.61M | 5.69M | |
| Average inventory | 1.16M | 17.3M | 15.97M | -11.51M | 24.35M | |
| Days sales outstanding | 190.68 | 136.88 | 173.74 | 201.22 | 184.14 | |
| Days payables outstanding | 107.58 | 153.97 | 188.91 | 249.62 | 0 | |
| Days of inventory on hand | 69.09 | 865.55 | -8.26 | -497.32 | 1.26K | |
| Receivables turnover | 1.91 | 2.67 | 2.1 | 1.81 | 1.98 | |
| Payables turnover | 3.39 | 2.37 | 1.93 | 1.46 | 0 | |
| Inventory turnover | 5.28 | 0.42 | -44.19 | -0.73 | 0.29 | |
| ROE | 0.02 | 0.04 | 0.05 | 0.04 | 0.02 | |
| Capex per share | -0.23 | -0.32 | -0.31 | -0.44 | -0.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.07 | 1.12 | 1.11 | 1.13 | 1.12 | |
| Net income per share | 0.22 | -0.29 | 0.26 | 0.14 | 0.18 | |
| Operating cash flow per share | 0.65 | 0.52 | 0.67 | 0.69 | 0.55 | |
| Free cash flow per share | 0.49 | 0.35 | 0.52 | 0.55 | 0.26 | |
| Cash per share | 1.43 | 0.83 | 1.03 | 1.29 | 0.13 | |
| Book value per share | 20.89 | 20.41 | 20.16 | 20.47 | 19.76 | |
| Tangible book value per share | 20.79 | -14.59 | 20.06 | 20.36 | 19.65 | |
| Share holders equity per share | 20.89 | 20.41 | 20.16 | 20.47 | 19.76 | |
| Interest debt per share | 14.99 | 15.73 | 15.01 | 16.07 | 15.87 | |
| Market cap | 851.57M | 886.71M | 827.65M | 757.77M | 692.13M | |
| Enterprise value | 1.19B | 1.25B | 1.2B | 1.16B | 1.1B | |
| P/E ratio | 40.64 | -32.03 | 31.46 | 54.25 | 37.89 | |
| Price to sales ratio | 33.6 | 32.63 | 29.76 | 26.37 | 23.77 | |
| POCF ratio | 55.26 | 69.83 | 49.63 | 42.77 | 48.43 | |
| PFCF ratio | 72.59 | 103.59 | 64.01 | 53.59 | 102.21 | |
| P/B Ratio | 1.71 | 1.79 | 1.64 | 1.45 | 1.35 | |
| PTB ratio | 1.71 | 1.79 | 1.64 | 1.45 | 1.35 | |
| EV to sales | 47.09 | 45.93 | 43.05 | 40.34 | 37.63 | |
| Enterprise value over EBITDA | 70.03 | 203.84 | 59.18 | 58.8 | 55.02 | |
| EV to operating cash flow | 77.44 | 98.29 | 71.79 | 65.42 | 76.68 | |
| EV to free cash flow | 101.72 | 145.81 | 92.59 | 81.98 | 161.84 | |
| Earnings yield | 0.01 | -0.01 | 0.01 | 0 | 0.01 | |
| Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Debt to equity | 0.71 | 0.76 | 0.74 | 0.78 | 0.79 | |
| Debt to assets | 0.4 | 0.43 | 0.41 | 0.42 | 0.43 | |
| Net debt to EBITDA | 20.06 | 59.02 | 18.27 | 20.36 | 20.27 | |
| Current ratio | 1.06 | 0.44 | 2.01 | 0.95 | 1.04 | |
| Interest coverage | 2.52 | -0.73 | 4.65 | 4.15 | 1.93 | |
| Income quality | 2.94 | -1.83 | 2.54 | 5.07 | 3.13 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Payout ratio | 2.15 | -1.68 | 1.8 | 3.48 | 2.72 | |
| Sales general and administrative to revenue | 0.16 | 0.6 | 0.14 | 0.13 | 0.13 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.96 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.24 | -0.33 | -0.22 | -0.2 | -0.53 | |
| Capex to revenue | -0.15 | -0.15 | -0.13 | -0.12 | -0.26 | |
| Capex to depreciation | -0.43 | -0.45 | -0.4 | -0.32 | -0.72 | |
| Stock based compensation to revenue | 0.1 | 0.53 | 0.06 | 0.07 | 0.07 | |
| Graham number | 10.17 | 11.46 | 10.91 | 7.94 | 8.84 | |
| ROIC | 0.01 | 0 | 0.02 | 0.02 | 0.01 | |
| Return on tangible assets | 0.01 | -0.18 | 0.01 | 0 | 0 | |
| Graham Net | -13.31 | -13.89 | -13.52 | -14.58 | -13.48 | |
| Working capital | 691K | -5.85M | 31.64M | -3.71M | 2.82M | |
| Tangible asset value | 494.42M | -353.55M | 502.77M | 519.44M | 510.61M | |
| Net current asset value | -367.54M | -387.15M | -332.26M | -368.35M | -361.93M | |
| Invested capital | 0.71 | 0.76 | 0.74 | 0.78 | 0.79 | |
| Average receivables | 51.56M | 55.93M | 57.14M | 56.45M | 56.78M | |
| Average payables | 9.76M | 10.93M | 10.54M | 13.03M | 7.72M | |
| Average inventory | -22.07M | -19.53M | -19.74M | -26.06M | 21.17M | |
| Days sales outstanding | 191.24 | 192.12 | 182.09 | 177.37 | 175.92 | |
| Days payables outstanding | 246.37 | 193.52 | 199.43 | 254.79 | 0 | |
| Days of inventory on hand | -490.86 | -302.84 | -434.11 | -479 | 1.15K | |
| Receivables turnover | 0.47 | 0.47 | 0.49 | 0.51 | 0.51 | |
| Payables turnover | 0.37 | 0.47 | 0.45 | 0.35 | 0 | |
| Inventory turnover | -0.18 | -0.3 | -0.21 | -0.19 | 0.08 | |
| ROE | 0.01 | -0.01 | 0.01 | 0.01 | 0.01 | |
| Capex per share | -0.15 | -0.17 | -0.15 | -0.14 | -0.29 |
CHCT Frequently Asked Questions
What is Community Healthcare Trust Incorporated stock symbol ?
Community Healthcare Trust Incorporated is a US stock , located in Franklin of Tn and trading under the symbol CHCT
What is Community Healthcare Trust Incorporated stock quote today ?
Community Healthcare Trust Incorporated stock price is $25.24 today.
Is Community Healthcare Trust Incorporated stock public?
Yes, Community Healthcare Trust Incorporated is a publicly traded company.
Company Profile
- Volume Average 195.11K
- Market Capitalization 696.18M
- Employee 37
- CEO Mr. David H. Dupuy
- Headquarters Franklin,TN,US
- IPO Date 2015-05-20
-
Website
https://www.chct.reit 
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. The Company had investments of approximately $667.3 million in 131 real estate properties as of September 30, 2020, located in 33 states, totaling approximately 2.8 million square feet.
